Inventor · disambiguated record
Derek E. Piper
Also filed as: PIPER DEREK E · PIPER DEREK EVAN
26 granted patents·21 pending applications·438 citations·filing 2003–2025
97Inventor score
Top patents by PatentIndex Score
47 records- 0199US8859741B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 14, 2014·51 cites·24 claims
- 0299US8829165B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2013·Granted Sep 9, 2014·76 cites·29 claims
- 0398US8883983B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Nov 11, 2014·26 cites·30 claims
- 0498US8871914B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 28, 2014·26 cites·25 claims
- 0598US8871913B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Oct 28, 2014·26 cites·29 claims
- 0698US8563698B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2009·Granted Oct 22, 2013·72 cites·6 claims
- 0797US9056915B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Jun 16, 2015·20 cites·23 claims
- 0897US9045547B2Methods of using antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2011·Granted Jun 2, 2015·42 cites·66 claims
- 0997US8889834B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Nov 18, 2014·25 cites·20 claims
- 1092US9920134B2Monoclonal antibodies to proprotein convertase subtilisin kexin type 9 (PCSK9)JACKSON SIMON MARK·Filed 2011·Granted Mar 20, 2018·13 cites·17 claims
- 1191US11891435B2Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereofAMGEN INC·Filed 2021·Granted Feb 6, 2024·1 cites·24 claims
- 1291US10738110B2PAC1 antibodies and uses thereofAMGEN INC·Filed 2019·Granted Aug 11, 2020·3 cites·17 claims
- 1390US8722033B2Human IL-23 antigen binding proteinsTOWNE JENNIFER E·Filed 2010·Granted May 13, 2014·14 cites·6 claims
- 1485US11248043B2Methods for treating a headache condition using anti-human PAC1 antibodies or antigen-binding fragments thereofAMGEN INC·Filed 2020·Granted Feb 15, 2022·1 cites·33 claims
- 1585US9493576B2Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (PCSK9)AMGEN INC·Filed 2014·Granted Nov 15, 2016·2 cites·43 claims
- 1683US7371381B2Anti-galanin antibodies and uses thereofAMGEN INC·Filed 2004·Granted May 13, 2008·24 cites·25 claims
- 1781US2025051457A1Asgr inhibitorsAMGEN INC·Filed 2024·Application pending·0 cites
- 1881US2024150448A1Pac1 antibodies and uses thereofAMGEN INC·Filed 2023·Application pending·0 cites
- 1980US12012449B2Human IL-23 antigen binding proteinsAMGEN INC·Filed 2021·Granted Jun 18, 2024·0 cites·1 claims
- 2078US9487580B2Human IL-23 antigen binding proteinsTOWNE JENNIFER E·Filed 2014·Granted Nov 8, 2016·2 cites·6 claims
- 2177US9951129B2Human IL-23 antigen binding proteinsAMGEN INC·Filed 2016·Granted Apr 24, 2018·1 cites·18 claims
- 2276US9994923B2Neutralizing proprotein convertase subtilisin kexin type 9 (PCSK9) variants and uses thereofJACKSON SIMON MARK·Filed 2009·Granted Jun 12, 2018·4 cites·19 claims
- 2376US2021230267A1Human IL-23 Antigen Binding ProteinsAMGEN INC·Filed 2021·Application pending·0 cites
- 2473US2021024626A1Human il-23 antigen binding proteinsAMGEN INC·Filed 2020·Application pending·0 cites
- 2572US7071358B2Arylsulfonamidobenzylic compoundsAMGEN INC·Filed 2003·Granted Jul 4, 2006·6 cites·25 claims
- 2672US2015031870A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2014·Application pending·0 cites
- 2771US2020181255A1Human IL-23 Antigen Binding ProteinsAMGEN INC·Filed 2020·Application pending·0 cites
- 2871US2015087819A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2014·Application pending·0 cites
- 2969US2019322737A1Human il-23 antigen binding proteinsAMGEN INC·Filed 2019·Application pending·0 cites
- 3067US7112606B2Heterocyclic arylsulfonamidobenzylic compoundsAMGEN INC·Filed 2003·Granted Sep 26, 2006·3 cites·8 claims
- 3167US2019071498A1Human IL-23 Antigen Binding ProteinsAMGEN INC·Filed 2018·Application pending·0 cites
- 3266US2013058944A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2012·Application pending·0 cites
- 3365US12331122B2Anti-ASGR-1 monoclonal inhibitory antibodiesAMGEN INC·Filed 2020·Granted Jun 17, 2025·0 cites·17 claims
- 3465US2013079501A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)JACKSON SIMON MARK·Filed 2012·Application pending·0 cites
- 3565US2012213797A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)JACKSON SIMON MARK·Filed 2012·Application pending·0 cites
- 3665US2013052201A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2012·Application pending·0 cites
- 3765US2012251544A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)JACKSON SIMON MARK·Filed 2012·Application pending·0 cites
- 3865US2013085265A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)JACKSON SIMON MARK·Filed 2012·Application pending·0 cites
- 3962US2025333536A1Mageb2 binding constructsAMGEN INC·Filed 2025·Application pending·0 cites
- 4062US2011027287A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)AMGEN INC·Filed 2010·Application pending·0 cites
- 4158US12312412B2MAGEB2 binding constructsAMGEN INC·Filed 2021·Granted May 27, 2025·0 cites·11 claims
- 4253US7473703B2Heterocyclic arylsulfonamidobenzylic compoundsAMGEN INC·Filed 2006·Granted Jan 6, 2009·0 cites·9 claims
- 4351US7326812B2Arylsulfonamidobenzylic compoundsAMGEN INC·Filed 2006·Granted Feb 5, 2008·0 cites·9 claims
- 4449US2022363770A1Anti-cgrp receptor/anti-pac1 receptor bispecific antigen binding proteinsAMGEN INC·Filed 2020·Application pending·0 cites
- 4548US2016032014A1Human antigen binding proteins that bind to proprotein convertase subtilisin kexin type 9AMGEN INC·Filed 2014·Application pending·0 cites
- 4642US2013072665A1Antigen binding proteins to proprotein convertase subtilisin kexin type 9 (pcsk9)JACKSON SIMON MARK·Filed 2012·Application pending·0 cites
- 4739US2015284471A1Human LCAT Antigen Binding Proteins and Their Use in TherapyAMGEN INC·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Derek E. Piper files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →